For instance, levels of BNP and NT-proBNP are influenced by comorbidities that are frequently associated with HFpEF, with atrial fibrillation and renal disease resulting in increased levels, and obesity leading to decreased levels of these NPs [22, 24]. This evidence concerns the gene NPPB and obesity disorder.